{"id":"preservative-free-eye-drop","safety":{"commonSideEffects":[{"rate":null,"effect":"Mild ocular irritation"},{"rate":null,"effect":"Transient blurred vision"},{"rate":null,"effect":"Foreign body sensation"}]},"_chembl":null,"_dailymed":{"setId":"ef5974b9-946c-4983-80e3-32b3aa28c207","title":"LUMIFY PRESERVATIVE FREE EYE DROPS (BRIMONIDINE TARTRATE) SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These drops deliver artificial tears or active pharmaceutical ingredients in a formulation free of antimicrobial preservatives, reducing the risk of preservative-induced ocular toxicity and irritation. They are typically dispensed in single-dose units or preservative-free multi-dose containers to maintain sterility without chemical additives. This formulation is particularly beneficial for patients with sensitive eyes or those requiring frequent instillation.","oneSentence":"Preservative-free eye drops provide lubrication and moisture to the ocular surface without chemical preservatives that may cause irritation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:02:35.315Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dry eye disease"},{"name":"Ocular surface irritation and lubrication"}]},"trialDetails":[{"nctId":"NCT07243275","phase":"PHASE4","title":"SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease","status":"RECRUITING","sponsor":"Indiana University","startDate":"2026-02-18","conditions":"Dry Eye Disease (DED)","enrollment":260},{"nctId":"NCT06544694","phase":"PHASE3","title":"A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2024-10-08","conditions":"Dry Eye Disease","enrollment":80},{"nctId":"NCT07151612","phase":"PHASE4","title":"The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia","status":"COMPLETED","sponsor":"Shanxi Eye Hospital","startDate":"2025-09-04","conditions":"Presbyopia","enrollment":62},{"nctId":"NCT04499248","phase":"PHASE1, PHASE2","title":"AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension","status":"RECRUITING","sponsor":"AbbVie","startDate":"2020-11-16","conditions":"Open-angle Glaucoma, Ocular Hypertension","enrollment":96},{"nctId":"NCT06660290","phase":"PHASE3","title":"A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2025-01-15","conditions":"Dry Eye Disease","enrollment":55},{"nctId":"NCT07224529","phase":"PHASE4","title":"Efficacy of Vevye Ophthalmic Solution for the Treatment of Meibomian Gland Dysfunction","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Meibomian Gland Dysfunction (MGD)","enrollment":48},{"nctId":"NCT07469865","phase":"NA","title":"Efficacy and Safety of 20% and 100% Autologous Serum Eye Drops in Patients With Severe Dry Eye Disease (AST)","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2021-11-30","conditions":"Dry Eye Disease","enrollment":46},{"nctId":"NCT05945615","phase":"PHASE3","title":"Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2024-01-11","conditions":"Blepharoptosis, Synkinesis, Hyperkinesis","enrollment":36},{"nctId":"NCT07456826","phase":"PHASE4","title":"Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections","status":"NOT_YET_RECRUITING","sponsor":"Harrow Inc","startDate":"2026-04","conditions":"Diabetic Macular Edema (DME), Age-Related Macular Degeneration (AMD), Retinal Vein Occlusion","enrollment":236},{"nctId":"NCT06190028","phase":"NA","title":"Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy","status":"TERMINATED","sponsor":"Fidia Farmaceutici s.p.a.","startDate":"2023-06-14","conditions":"Dry Eye Syndrome, Glaucoma and Concomitant Dry Eye Syndrome, Ocular Hypertension and Concomitant Dry Eye Syndrome","enrollment":65},{"nctId":"NCT06030193","phase":"PHASE2","title":"Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma (NTG)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qlaris Bio, Inc.","startDate":"2025-08-13","conditions":"Normal Tension Glaucoma (NTG), Low-Tension Glaucoma, Bilateral, Low-Tension Glaucoma, Unspecified Eye","enrollment":36},{"nctId":"NCT07394257","phase":"NA","title":"Intrastromal Moxifloxacin as an Adjunctive Therapy in Recalcitrant Bacterial Keratitis","status":"RECRUITING","sponsor":"Minia University","startDate":"2025-10-01","conditions":"Bacterial Keratitis, Recalcitrant Infectious Keratitis, Corneal Ulcer","enrollment":60},{"nctId":"NCT04505566","phase":"PHASE1","title":"INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stephen J. Kim, MD","startDate":"2020-11-09","conditions":"Diabetic Retinopathy","enrollment":164},{"nctId":"NCT06394973","phase":"PHASE2","title":"Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2024-08-05","conditions":"Glaucoma, Ocular Hypertension","enrollment":161},{"nctId":"NCT05555589","phase":"PHASE3","title":"Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2","status":"RECRUITING","sponsor":"ReGenTree, LLC","startDate":"2023-04-11","conditions":"Neurotrophic Keratopathy","enrollment":70},{"nctId":"NCT06966349","phase":"PHASE4","title":"Quantifying Ocular Surface Aberrations After Tear Film Interventions","status":"RECRUITING","sponsor":"University of Waterloo","startDate":"2025-06-10","conditions":"Tear Film Characteristics","enrollment":12},{"nctId":"NCT07007702","phase":"","title":"Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease","status":"COMPLETED","sponsor":"Laboratoires Thea","startDate":"2025-01-27","conditions":"Dry Eye Disease (DED)","enrollment":30},{"nctId":"NCT04125134","phase":"PHASE4","title":"Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests","status":"TERMINATED","sponsor":"Tufts Medical Center","startDate":"2019-10-03","conditions":"Dry Eye","enrollment":36},{"nctId":"NCT06903884","phase":"PHASE3","title":"3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-12-30","conditions":"Vernal Keratoconjunctivitis","enrollment":94},{"nctId":"NCT05902364","phase":"NA","title":"Systane® Ultra Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-10-28","conditions":"Dry Eye","enrollment":69},{"nctId":"NCT06571656","phase":"NA","title":"Evaluation of the Safety and Tolerability of Ocular Lubricants","status":"TERMINATED","sponsor":"Alcon Research","startDate":"2025-04-02","conditions":"Dry Eye Disease","enrollment":73},{"nctId":"NCT07064187","phase":"PHASE4","title":"Evaluate The Improvement In Symptoms Of Patients Using Cationorm After Pterygium Surgery","status":"COMPLETED","sponsor":"Nguyen Viet Giap","startDate":"2022-06-15","conditions":"Ocular Discomfort","enrollment":100},{"nctId":"NCT07090044","phase":"PHASE4","title":"Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period","status":"COMPLETED","sponsor":"Retina Research Institute, LLC","startDate":"2021-08-20","conditions":"Vein Occlusion, Macular Degeneration Choroidal Neovascularization, Macular Edema","enrollment":77},{"nctId":"NCT05682547","phase":"NA","title":"Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye","status":"COMPLETED","sponsor":"He Eye Hospital","startDate":"2022-12-01","conditions":"Diabetic Eye Problems","enrollment":99},{"nctId":"NCT06443775","phase":"","title":"An Observational Study to Assess Next Generation Emulsion Preservative Free Eye Drops (NGE-UD) on Dry Eye Symptoms and Quality of Life of Adult Participants With Mild to Moderate Dry Eye Disease (DED)","status":"COMPLETED","sponsor":"AbbVie","startDate":"2024-06-17","conditions":"Dry Eye","enrollment":47},{"nctId":"NCT06655441","phase":"PHASE4","title":"The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function","status":"NOT_YET_RECRUITING","sponsor":"Southern California College of Optometry at Marshall B. Ketchum University","startDate":"2025-09-01","conditions":"Dry Eye Disease (DED)","enrollment":30},{"nctId":"NCT03162497","phase":"PHASE4","title":"Effect of Topical Azithromycin on Tear Film Thickness in Patients With Meibomian Gland Dysfunction","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-01-08","conditions":"Dry Eye Syndromes, Meibomian Gland Dysfunction","enrollment":23},{"nctId":"NCT05814367","phase":"PHASE2","title":"Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops","status":"COMPLETED","sponsor":"Johnson & Johnson Vision Care, Inc.","startDate":"2023-04-06","conditions":"Visual Acuity","enrollment":46},{"nctId":"NCT05661851","phase":"PHASE2","title":"Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients","status":"COMPLETED","sponsor":"Johnson & Johnson Vision Care, Inc.","startDate":"2023-02-23","conditions":"Dry Eye","enrollment":121},{"nctId":"NCT06921525","phase":"PHASE1, PHASE2","title":"Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye","status":"NOT_YET_RECRUITING","sponsor":"Ehab Mohamed Elsayed Mohamed Saad","startDate":"2025-04-01","conditions":"Dry Eye","enrollment":44},{"nctId":"NCT05932225","phase":"NA","title":"Systane® Complete Preservative Free Lubricant Eye Drops","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-08-18","conditions":"Dry Eye","enrollment":71},{"nctId":"NCT06163105","phase":"NA","title":"The Effect of Gland Expression on the Regeneration of Meibomian Gland","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2024-10-03","conditions":"Meibomian Gland Dysfunction","enrollment":64},{"nctId":"NCT05705518","phase":"PHASE4","title":"Artificial Tears, Tear Lipids and Tear Film Dynamics","status":"COMPLETED","sponsor":"University of California, Berkeley","startDate":"2023-01-30","conditions":"Dry Eye","enrollment":81},{"nctId":"NCT03193333","phase":"PHASE3","title":"PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)","status":"TERMINATED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2017-11-06","conditions":"Primary Open-angle Glaucoma","enrollment":51},{"nctId":"NCT06860659","phase":"PHASE4","title":"Efficacy of 0.28% Sodium Hyaluronate Eye Drops in Patient with Moderate to Severe Dry Eye","status":"ENROLLING_BY_INVITATION","sponsor":"Department of Medical Services Ministry of Public Health of Thailand","startDate":"2024-09-01","conditions":"Dry Eye Disease (DED), Tear Break-Up Time, Tear Disorder","enrollment":84},{"nctId":"NCT05832996","phase":"PHASE4","title":"Cool vs Room-temperature Artificial Tears","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2022-03-01","conditions":"Diabetic Retinopathy With Macular Edema of Both Eyes (Diagnosis), Central Retinal Vein Occlusion With Macular Edema, Exudative Age-Related Macular Degeneration, Unspecified Eye","enrollment":124},{"nctId":"NCT06671041","phase":"PHASE4","title":"Treating Lid Wiper Epitheliopathy","status":"COMPLETED","sponsor":"Southern College of Optometry","startDate":"2024-05-27","conditions":"Dry Eye, Visual Acuity","enrollment":52},{"nctId":"NCT06822608","phase":"PHASE4","title":"Evaluation of Dexpanthenol and Hyaluronic Acid Eye Drops on Corneal Epithelialization After Trans Epithelial PRK","status":"NOT_YET_RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2025-02","conditions":"Corneal Epithelial Wound Healing","enrollment":68},{"nctId":"NCT06798025","phase":"NA","title":"Three Different Modalities for Treatment of Inflammatory Punctal Stenosis","status":"COMPLETED","sponsor":"Tanta University","startDate":"2023-07-20","conditions":"Modalities, Treatment, Inflammatory Punctal Stenosis","enrollment":60},{"nctId":"NCT04857827","phase":"PHASE2","title":"A Study to Evaluate Safety and Tolerability of QLS-101 in NTG","status":"COMPLETED","sponsor":"Qlaris Bio, Inc.","startDate":"2021-09-15","conditions":"Normal Tension Glaucoma (NTG)","enrollment":30},{"nctId":"NCT06249152","phase":"PHASE2","title":"Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients","status":"COMPLETED","sponsor":"Qlaris Bio, Inc.","startDate":"2024-04-21","conditions":"Open-angle Glaucoma (OAG), Ocular Hypertension (OHT), Glaucoma","enrollment":36},{"nctId":"NCT06016972","phase":"PHASE2","title":"Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients","status":"COMPLETED","sponsor":"Qlaris Bio, Inc.","startDate":"2024-03-05","conditions":"Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye","enrollment":63},{"nctId":"NCT04830397","phase":"PHASE2","title":"Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension).","status":"COMPLETED","sponsor":"Qlaris Bio, Inc.","startDate":"2021-03-31","conditions":"Primary Open Angle Glaucoma, Ocular Hypertension","enrollment":84},{"nctId":"NCT04324359","phase":"PHASE2","title":"Study to See How Well an Eye Drop, SURF-201, Works and What Side Effects There Are in Cataract Surgery Subjects","status":"COMPLETED","sponsor":"Surface Ophthalmics, Inc.","startDate":"2020-03-03","conditions":"Post-surgical Ocular Inflammation, Post-surgical Ocular Pain","enrollment":91},{"nctId":"NCT06731725","phase":"NA","title":"Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye","status":"COMPLETED","sponsor":"i+Med S.Coop.","startDate":"2021-02-17","conditions":"Dry Eye, Dry Eye Syndrome (DES)","enrollment":20},{"nctId":"NCT05857267","phase":"PHASE4","title":"Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety","status":"COMPLETED","sponsor":"Laboratorios Poen","startDate":"2023-03-07","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":84},{"nctId":"NCT05932238","phase":"NA","title":"Systane® Hydration PF and Systane® Hydration Preserved","status":"COMPLETED","sponsor":"Alcon Research","startDate":"2023-10-06","conditions":"Dry Eye","enrollment":137},{"nctId":"NCT05360784","phase":"PHASE3","title":"\"Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness\"","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2022-05-13","conditions":"Ocular Redness","enrollment":380},{"nctId":"NCT04050644","phase":"PHASE4","title":"Comparison of Treatment With Preservative-free Dexamethasone 0.1% (Monofree Dexamethason) and Diclofenac 0.1% (Dicloabak) Eye Drops Versus Preserved Dexamethasone 0.1% (Maxidex) and Diclofenac 0.1% (Voltaren Ophtha) Eye Drops After Cataract Surgery","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2018-10-30","conditions":"Age-related Cataract","enrollment":100},{"nctId":"NCT04133311","phase":"PHASE3","title":"A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Santen SAS","startDate":"2019-04-10","conditions":"Open-Angle Glaucoma or Ocular Hypertension, Ocular Surface Disease","enrollment":386},{"nctId":"NCT06404541","phase":"PHASE4","title":"A Comparative Study Between Preservative With Benzalkonium Chloride vs Preservative Free Eye Drops on the Ocular Surface","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kasr El Aini Hospital","startDate":"2024-01-10","conditions":"Ocular Surface Disease, Dry Eye Syndromes","enrollment":60},{"nctId":"NCT03653650","phase":"NA","title":"Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2018-08-30","conditions":"Persistent Epithelial Defect","enrollment":54},{"nctId":"NCT04604834","phase":"NA","title":"Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2020-11-01","conditions":"Neurotrophic Keratopathy","enrollment":39},{"nctId":"NCT05778942","phase":"","title":"Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness","status":"COMPLETED","sponsor":"SIFI SpA","startDate":"2023-02-23","conditions":"Dry Eye Syndromes","enrollment":35},{"nctId":"NCT06221345","phase":"PHASE4","title":"Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-12-07","conditions":"Dry Eye Disease, Cataract","enrollment":70},{"nctId":"NCT04327999","phase":"PHASE2","title":"Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System","status":"TERMINATED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2020-10-05","conditions":"Thyroid Carcinoma, Radioactive Iodine Level","enrollment":9},{"nctId":"NCT04515329","phase":"PHASE4","title":"Tear Film Markers in Dry Eye Syndrome","status":"WITHDRAWN","sponsor":"Vishal Jhanji","startDate":"2023-12-08","conditions":"Dry Eye","enrollment":""},{"nctId":"NCT06159569","phase":"NA","title":"Performance and Tolerability of the Medical Device LACRIACT","status":"COMPLETED","sponsor":"Laboratórios Baldacci S.A","startDate":"2021-09-09","conditions":"Dry Eye, Contact Lens Acute Red Eye, Photophobia","enrollment":20},{"nctId":"NCT04702789","phase":"PHASE4","title":"Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.","status":"TERMINATED","sponsor":"Laboratorios Sophia S.A de C.V.","startDate":"2021-10-19","conditions":"Glaucoma, Open-Angle, Ocular Hypertension","enrollment":28},{"nctId":"NCT06162442","phase":"","title":"Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye","status":"UNKNOWN","sponsor":"Tecnoquimicas","startDate":"2023-03-15","conditions":"Dry Eye Disease","enrollment":132},{"nctId":"NCT06148428","phase":"","title":"Anxiety-related Fixation Instability During LASIK","status":"COMPLETED","sponsor":"Assiut University","startDate":"2018-08-15","conditions":"Refractive Errors","enrollment":2435},{"nctId":"NCT06034366","phase":"NA","title":"the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression","status":"UNKNOWN","sponsor":"He Eye Hospital","startDate":"2023-10-01","conditions":"Myopia","enrollment":150},{"nctId":"NCT04957329","phase":"PHASE4","title":"Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-09-01","conditions":"Glaucoma, Ocular Hypertension","enrollment":28},{"nctId":"NCT05753787","phase":"NA","title":"Eye Surface Properties After Using Dexamethasone Drops With and Without Preservatives in Patients After Cataract Surgery","status":"UNKNOWN","sponsor":"Spektrum Center of Clinical Ophthalmology","startDate":"2022-01-01","conditions":"Cataract, Surgical Injury, Healing Wound","enrollment":40},{"nctId":"NCT04465071","phase":"NA","title":"Lubricating Eye Drops After Routine Cataract Surgery","status":"COMPLETED","sponsor":"Guy's and St Thomas' NHS Foundation Trust","startDate":"2020-02-24","conditions":"Dry Eye, Cataract","enrollment":79},{"nctId":"NCT05618730","phase":"PHASE1","title":"Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B","status":"UNKNOWN","sponsor":"Eximore Ltd.","startDate":"2022-09-29","conditions":"Dry Eye, Keratoconjunctivitis Sicca, Ocular Inflammation","enrollment":20},{"nctId":"NCT05660681","phase":"NA","title":"Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops","status":"COMPLETED","sponsor":"Calm Water Therapeutics LLC","startDate":"2022-12-12","conditions":"Dry Eye Disease","enrollment":34},{"nctId":"NCT02600429","phase":"PHASE3","title":"Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1","status":"TERMINATED","sponsor":"ReGenTree, LLC","startDate":"2015-09-17","conditions":"Neurotrophic Keratopathy","enrollment":18},{"nctId":"NCT03822559","phase":"PHASE3","title":"A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension","status":"COMPLETED","sponsor":"Santen Pharmaceutical Co., Ltd.","startDate":"2019-01-20","conditions":"Open-angle Glaucoma, Ocular Hypertension","enrollment":219},{"nctId":"NCT05940376","phase":"","title":"Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy","status":"UNKNOWN","sponsor":"Benha University","startDate":"2023-07-15","conditions":"Corneal Ulcer, Neurotrophic Corneal Ulcer, Diabetes Mellitus","enrollment":30},{"nctId":"NCT05733741","phase":"PHASE4","title":"Preservative-free Topical Anesthetics for Post-PRK Pain","status":"COMPLETED","sponsor":"Assiut University","startDate":"2023-01-30","conditions":"Myopia","enrollment":70},{"nctId":"NCT03634852","phase":"PHASE4","title":"A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery","status":"COMPLETED","sponsor":"Suzan A Rattan","startDate":"2016-10-01","conditions":"Endophthalmitis Postoperative","enrollment":1000},{"nctId":"NCT05292755","phase":"PHASE4","title":"Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome","status":"COMPLETED","sponsor":"University of Florida","startDate":"2022-04-22","conditions":"Dry Eye Syndromes","enrollment":80},{"nctId":"NCT04980144","phase":"NA","title":"Diquafosol Ophthalmic Solution for Dry Eye Symptoms","status":"UNKNOWN","sponsor":"He Eye Hospital","startDate":"2023-03-03","conditions":"Diabetic Eye Problems","enrollment":101},{"nctId":"NCT03803748","phase":"NA","title":"A Non-inferiority Study of Eyestil® Plus Multidose Versus Vismed Multi®","status":"COMPLETED","sponsor":"SIFI SpA","startDate":"2019-07-17","conditions":"Dry Eye Syndromes","enrollment":96},{"nctId":"NCT04776096","phase":"PHASE4","title":"Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis Treatment","status":"COMPLETED","sponsor":"Laboratorios Poen","startDate":"2021-03-10","conditions":"Allergic Conjunctivitis","enrollment":97},{"nctId":"NCT05606796","phase":"PHASE4","title":"Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.","status":"UNKNOWN","sponsor":"Uzoma Chinyei Joan","startDate":"2022-12","conditions":"Effect of Drug","enrollment":76},{"nctId":"NCT04054830","phase":"PHASE4","title":"Steroids and/ or Non-steroidal Anti-inflammatory Drugs in the Postoperative Regime After Trabeculectomy.","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2019-08-01","conditions":"Glaucoma","enrollment":70},{"nctId":"NCT05564832","phase":"EARLY_PHASE1","title":"Pharmacological Treatment of Presbyopia","status":"UNKNOWN","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2022-08-01","conditions":"Near Vision","enrollment":75},{"nctId":"NCT04673604","phase":"NA","title":"From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2018-05-06","conditions":"Glaucoma, Ocular Surface Disease","enrollment":42},{"nctId":"NCT05429229","phase":"PHASE2","title":"Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Adolfo Daniel Rodriguez-Carrizalez","startDate":"2021-11-01","conditions":"Dry Eye Syndromes, Diabetic Retinopathy, Oxidative Stress","enrollment":78},{"nctId":"NCT05428683","phase":"NA","title":"Intravitreal Triamcinolone and Moxifloxacin Injection After Cataract Surgery","status":"COMPLETED","sponsor":"Emad Abdel Aal Saliem","startDate":"2020-12-03","conditions":"Pharmacological Action","enrollment":84},{"nctId":"NCT05433428","phase":"PHASE4","title":"Metabolomic Profile in Dry Eye Syndrome Patients.","status":"UNKNOWN","sponsor":"Ifocus Oyeklinikk","startDate":"2020-08-03","conditions":"Dry Eye Syndromes, Cataract","enrollment":250},{"nctId":"NCT05165290","phase":"PHASE3","title":"Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure","status":"UNKNOWN","sponsor":"TearClear Corp","startDate":"2021-11-29","conditions":"Elevated Intraocular Pressure","enrollment":300},{"nctId":"NCT03803722","phase":"NA","title":"To Demonstrate the Non-inferiority of Eyestil Protection® Compared to Vismed® in Terms of Clinical Performance","status":"TERMINATED","sponsor":"SIFI SpA","startDate":"2019-07-08","conditions":"Dry Eye Syndrome","enrollment":21},{"nctId":"NCT03937882","phase":"PHASE3","title":"Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3","status":"COMPLETED","sponsor":"ReGenTree, LLC","startDate":"2019-05-24","conditions":"Dry Eye Syndromes, Dry Eye","enrollment":700},{"nctId":"NCT02533154","phase":"PHASE4","title":"Effect of Benzalkonium Chloride Containing Eye Drops on the Conjunctival Bacterial Flora of Dry Eye Patients","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2015-07-27","conditions":"Dry Eye Syndromes","enrollment":40},{"nctId":"NCT02974907","phase":"PHASE3","title":"Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2","status":"COMPLETED","sponsor":"ReGenTree, LLC","startDate":"2016-11","conditions":"Dry Eye Syndrome","enrollment":601},{"nctId":"NCT05145959","phase":"NA","title":"Meibomian Gland Probing in the Sub-Acute Phase of Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis","status":"UNKNOWN","sponsor":"Massachusetts Eye and Ear Infirmary","startDate":"2021-12-01","conditions":"Stevens-Johnson Syndrome, Toxic Epidermal Necrolyses, Ocular Surface Disease","enrollment":30},{"nctId":"NCT05064189","phase":"NA","title":"Protection of Corneal Epithelium Using Chitosan-N-acetylcysteine Eye Drops During and/or After Cataract Surgery","status":"COMPLETED","sponsor":"Vienna Institute for Research in Ocular Surgery","startDate":"2021-04-14","conditions":"Eye Diseases","enrollment":45},{"nctId":"NCT05053789","phase":"NA","title":"Efficacy of Different Treatment Regimens With Chitosan-N- Acetylcysteine in Moderate-to-severe Dry Eye Disease","status":"TERMINATED","sponsor":"Vienna Institute for Research in Ocular Surgery","startDate":"2021-05-12","conditions":"Eye Diseases","enrollment":48},{"nctId":"NCT03640650","phase":"PHASE4","title":"Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study.","status":"TERMINATED","sponsor":"PeriPharm","startDate":"2018-08-15","conditions":"Cataract Surgery","enrollment":80},{"nctId":"NCT05049629","phase":"NA","title":"Effect of Chitosan-N-Acetylcysteine on IOL-power Prior to Cataract Surgery","status":"TERMINATED","sponsor":"Vienna Institute for Research in Ocular Surgery","startDate":"2021-05-12","conditions":"Eye Diseases","enrollment":30},{"nctId":"NCT05049642","phase":"NA","title":"Effect of Chitosan-N-acetylcysteine on Subjective Pain Sensation in Corneal Abrasion","status":"TERMINATED","sponsor":"Vienna Institute for Research in Ocular Surgery","startDate":"2021-05-12","conditions":"Eye Diseases","enrollment":30},{"nctId":"NCT03414645","phase":"PHASE1, PHASE2","title":"Topical Fibrinogen-Depleted Human Platelet Lysate in Patients With Dry Eye Secondary to Graft vs. Host Disease","status":"COMPLETED","sponsor":"Cambium Bio Limited","startDate":"2018-05-01","conditions":"Dry Eye, Graft-versus-host-disease, Ocular Discomfort","enrollment":64},{"nctId":"NCT04896125","phase":"","title":"Comparison of Different Drugs on Ocular Surface Disease in Glaucoma Patients: a Prospective Randomised Study","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2019-10-02","conditions":"Glaucoma; Ocular Disorders (I.E. Caused by Ocular Disorders)","enrollment":300},{"nctId":"NCT04891588","phase":"NA","title":"Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD","status":"UNKNOWN","sponsor":"Klinički Bolnički Centar Zagreb","startDate":"2021-03-08","conditions":"Primary Open-angle Glaucoma, Ocular Hypertension","enrollment":50},{"nctId":"NCT00748059","phase":"PHASE1","title":"The Pathophysiology of Orthostatic Hypotension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1996-12","conditions":"Autonomic Nervous System Diseases, Orthostatic Hypotension, Dopamine Beta-Hydroxylase Deficiency","enrollment":10},{"nctId":"NCT04743622","phase":"PHASE4","title":"Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost","status":"COMPLETED","sponsor":"CHA University","startDate":"2019-04-30","conditions":"Glaucoma, Ocular Hypertension","enrollment":57},{"nctId":"NCT02802137","phase":"PHASE4","title":"24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2015-03","conditions":"Glaucoma, Ocular Surface Disease","enrollment":43}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"EXPIRED DRUG ADMINISTERED"},{"count":1,"reaction":"HORDEOLUM"},{"count":1,"reaction":"INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION"},{"count":1,"reaction":"INCORRECT DOSE ADMINISTERED"},{"count":1,"reaction":"WRONG TECHNIQUE IN DRUG USAGE PROCESS"}],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Preservative Free eye drop","genericName":"Preservative Free eye drop","companyName":"Southern College of Optometry","companyId":"southern-college-of-optometry","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Preservative-free eye drops have been studied in clinical trials for various eye conditions, including Neurotrophic Keratopathy, Vein Occlusion, Macular Degeneration Choroidal Neovascularization, Macular Edema, and Diabetic Retinopathy. The specific preservative-free eye drops studied include PFAT, APRP, and Bromfenac Sodium 0.07%, which have been investigated as potential treatments for these conditions.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}